The DOI matches its Crossref record; 266 of the 266 references it cites were found in a registry or an index.
Molecular Targets of Cannabidiol in Neurological Disorders
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Heng, L., Huang, B., Guo, H., Ma, L., Yuan, W., Song, J., Wang, P., Xu, G., & Gao, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104546 · Cited by 24
RetractedAlzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · cited 1×
“As it is associated with the e x c e s s i v e bu i l d - up o f β - amy l o i d (Aβ ) a n d hyperphosphorylated forms of the microtubuleassociated protein, tau, this led to the proposal of the Bamyloid cascade hypothesis^ as the underlying pathogenic basis for this disease [187].”
BackgroundNeuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
Geisler, S., Holmström, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J., & Springer, W. (2010) · Nature Cell Biology · doi:10.1038/ncb2012 · Cited by 2,835 · cited 1×
“This causes the loss of dopaminergic neurons, leading to the movement disorders seen in PD [166].”
BackgroundOpioid Complications and Side Effects
Benyamin, R. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/s105 · Cited by 2,245
Pertwee, R. G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 1,935
Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance
Calder, P. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.010 · Cited by 1,717
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,587
The orphan receptor GPR55 is a novel cannabinoid receptor
Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568 · cited 7×
“While the pharmacology and localization of GPR55merits further investigation [20, 53], CBD has demonstrable antagonistic effects within rat brain with clear physiological relevance.”
BackgroundInfluentialBisogno, T., Hanuš, L., De Petrocellis, L., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Di Marzo, V. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,311
The separation of synaptic vesicles from nerve-ending particles (‘synaptosomes’)
Whittaker, V., Michaelson, I., & Kirkland, R. (1964) · Biochemical Journal · doi:10.1042/bj0900293 · Cited by 1,199
Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis
Vowles, K. E., McEntee, M. L., Julnes, P. S., Frohe, T., Ney, J. P., & van der Goes, D. N. (2015) · Pain · doi:10.1097/01.j.pain.0000460357.01998.f1 · Cited by 1,154
Sindrup, S. H., & Jensen, T. S. (1999) · Pain · doi:10.1016/s0304-3959(99)00154-2 · Cited by 1,144
Omega-3 Fatty Acids and Inflammatory Processes
Calder, P. C. (2010) · Nutrients · doi:10.3390/nu2030355 · Cited by 1,116
Molecular mechanisms of opioid receptor-dependent signaling and behavior
Al-Hasani, R., & Bruchas, M. R. (2011) · Anesthesiology · doi:10.1097/aln.0b013e318238bba6 · Cited by 1,067
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
Leweke, F. M., Piomelli, D., Pahlisch, F., Muhl, D., Gerth, C. W., Hoyer, C., Klosterkötter, J., Hellmich, M., & Koethe, D. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.15 · Cited by 1,059 · cited 1×
“FAAH inhibition also alleviates psychotic symptoms in patients with schizophrenia [281].”
BackgroundThe Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation
Bryan, H. K., Olayanju, A., Goldring, C. E., & Park, B. K. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.11.016 · Cited by 1,024
Devinsky, O., Cilio, M. R., Cross, H., Fernandez‐Ruiz, J., French, J., Hill, C., Katz, R., Di Marzo, V., Jutras‐Aswad, D., Notcutt, W. G., et al. (2014) · Epilepsia · doi:10.1111/epi.12631 · Cited by 1,000 · cited 2×
“sy, although, confusingly, significant reports of proconvulsant effects are also present in the literature (for a detailed review see [124]).”
BackgroundSelf-citationDe Petrocellis, L., Ligresti, A., Moriello, A. S., Allarà, M., Bisogno, T., Petrosino, S., Stott, C. G., & Di Marzo, V. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01166.x · Cited by 946
Agonistic properties of cannabidiol at 5-HT1a receptors
Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6978-1 · Cited by 878
Cannabidiol and (−)Δ 9 -tetrahydrocannabinol are neuroprotective antioxidants
Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8268 · Cited by 850 · cited 1×
“Finally, one property of CBD that has long thought to be important in its mode of action is its ability to act as an antioxidant and was originally considered to arise from its ability to directly scavenge ROS [218, 219].”
BackgroundPolymorphism of human cytochrome P450 enzymes and its clinical impact
Zhou, S.-F., Liu, J.-P., & Chowbay, B. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902843483 · Cited by 826
VDAC, a multi-functional mitochondrial protein regulating cell life and death
Shoshan-Barmatz, V., De Pinto, V., Zweckstetter, M., Raviv, Z., Keinan, N., & Arbel, N. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.03.002 · Cited by 782
Molecular Structure and Function of the Glycine Receptor Chloride Channel
Lynch, J. W. (2004) · Physiological Reviews · doi:10.1152/physrev.00042.2003 · Cited by 778
Thomas, A., Baillie, G. L., Phillips, A. M., Razdan, R. K., Ross, R. A., & Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707133 · Cited by 756
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
Lauckner, J. E., Jensen, J. B., Chen, H.-Y., Lu, H.-C., Hille, B., & Mackie, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711278105 · Cited by 712
Járai, Z., Wagner, J. A., Varga, K., Lake, K. D., Compton, D. R., Martin, B. R., Zimmer, A. M., Bonner, T. I., Buckley, N. E., Mezey, E., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14136 · Cited by 599
Ligresti, A., Moriello, A. S., Starowicz, K., Matias, I., Pisanti, S., De Petrocellis, L., Laezza, C., Portella, G., Bifulco, M., & Di Marzo, V. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105247 · Cited by 568
Epidemiology of Dementias and Alzheimer’s Disease
Sosa-Ortiz, A. L., Acosta-Castillo, I., & Prince, M. J. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.11.003 · Cited by 553
Mitohormesis: Promoting Health and Lifespan by Increased Levels of Reactive Oxygen Species (ROS)
Ristow, M., & Schmeisser, K. (2014) · Dose-Response · doi:10.2203/dose-response.13-035.ristow · Cited by 534 · cited 2×
“That TRPV1 can both enhance and inhibit mitochondrial function can be reconciled by the fact that calcium tightly controls mitochondrial function and biogenesis such that a small amount can stimulate function but too much can induce apoptosis [212, 233].”
BackgroundMcPartland, J. M., Duncan, M., Di Marzo, V., & Pertwee, R. G. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12944 · Cited by 521
Carrier, E. J., Auchampach, J. A., & Hillard, C. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511232103 · Cited by 497
Drug–drug interaction between clobazam and cannabidiol in children with refractory epilepsy
Geffrey, A. L., Pollack, S. F., Bruno, P. L., & Thiele, E. A. (2015) · Epilepsia · doi:10.1111/epi.13060 · Cited by 496
The human fatty acid-binding protein family: Evolutionary divergences and functions
Smathers, R. L., & Petersen, D. R. (2011) · Human Genomics · doi:10.1186/1479-7364-5-3-170 · Cited by 492
Identification of GPR55 as a lysophosphatidylinositol receptor
Oka, S., Nakajima, K., Yamashita, A., Kishimoto, S., & Sugiura, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.078 · Cited by 459
COYLE, J. T., & SNYDER, S. H. (1969) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)28416-6 · Cited by 453
Shrivastava, A., Kuzontkoski, P. M., Groopman, J. E., & Prasad, A. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-1100 · Cited by 449
Adenosine receptors and brain diseases: neuroprotection and neurodegeneration
Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.001 · Cited by 419
Borlongan, C., Acosta, S., de la Pena, I., Tajiri, N., Kaneko, Y., Lozano, D., & Gonzales-Portillo, G. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s65815 · Cited by 415
Iannotti, F. A., Hill, C. L., Leo, A., Alhusaini, A., Soubrane, C., Mazzarella, E., Russo, E., Whalley, B. J., Di Marzo, V., & Stephens, G. J. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5000524 · Cited by 413
Self-citationEsposito, G., Scuderi, C., Valenza, M., Togna, G. I., Latina, V., De Filippis, D., Cipriano, M., Carratù, M. R., Iuvone, T., & Steardo, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028668 · Cited by 410 · cited 1×
“Here, the protective effects of CBD in an Aβ-induced neuroinflammatory mouse model were abolished by a PPARγ antagonist, but no evidence was given as to whether this was a direct or indirect effect [198].”
BackgroundAltered Lipid Metabolism in Brain Injury and Disorders
Adibhatla, R. M., & Hatcher, J. F. (2008) · Subcellular Biochemistry · doi:10.1007/978-1-4020-8831-5_9 · Cited by 401
Deiana, S., Watanabe, A., Yamasaki, Y., Amada, N., Arthur, M., Fleming, S., Woodcock, H., Dorward, P., Pigliacampo, B., Close, S., et al. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2415-0 · Cited by 398
Qin, N., Neeper, M. P., Liu, Y., Hutchinson, T. L., Lubin, M. L., & Flores, C. M. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0504-08.2008 · Cited by 396
Costa, B., Trovato, A. E., Comelli, F., Giagnoni, G., & Colleoni, M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.006 · Cited by 395
An archaeological and historical account of cannabis in China
Li, H.-L. (1973) · Economic Botany · doi:10.1007/bf02862859 · Cited by 386
Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors
Kathmann, M., Flau, K., Redmer, A., Tränkle, C., & Schlicker, E. (2006) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-006-0033-x · Cited by 377
Wu, H.-Y., Hudry, E., Hashimoto, T., Kuchibhotla, K., Rozkalne, A., Fan, Z., Spires-Jones, T., Xie, H., Arbel-Ornath, M., Grosskreutz, C. L., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4456-09.2010 · Cited by 367 · cited 1×
“pathway, both in vivo and in vitro, can reverse markers of neurodegeneration [205].”
Antidepressant‐like effects of cannabidiol in mice: possible involvement of 5‐HT1Areceptors
Zanelati, T., Biojone, C., Moreira, F., Guimarães, F., & Joca, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00521.x · Cited by 366
Role of Redox Signaling in Neuroinflammation and Neurodegenerative Diseases
Hsieh, H.-L., & Yang, C.-M. (2013) · BioMed Research International · doi:10.1155/2013/484613 · Cited by 365
Porter, B. E., & Jacobson, C. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.08.037 · Cited by 359
Mechanisms of Glutamate Transport
Vandenberg, R. J., & Ryan, R. M. (2013) · Physiological Reviews · doi:10.1152/physrev.00007.2013 · Cited by 350
Fernández‐Ruiz, J., Sagredo, O., Pazos, M. R., García, C., Pertwee, R., Mechoulam, R., & Martínez‐Orgado, J. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04341.x · Cited by 349
In silico patent searching reveals a new cannabinoid receptor
Baker, D., Pryce, G., Davies, W. L., & Hiley, C. R. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.003 · Cited by 348
Cremesti, A. E., Goni, F. M., & Kolesnick, R. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03489-0 · Cited by 342
De Petrocellis, L., Vellani, V., Schiano-Moriello, A., Marini, P., Magherini, P. C., Orlando, P., & Di Marzo, V. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.134809 · Cited by 336
The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo
Whyte, L. S., Ryberg, E., Sims, N. A., Ridge, S. A., Mackie, K., Greasley, P. J., Ross, R. A., & Rogers, M. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902743106 · Cited by 330
Current Research on Opioid Receptor Function
Feng, Y., He, X., Yang, Y., Chao, D., H. Lazarus, L., & Xia, Y. (2012) · Current Drug Targets · doi:10.2174/138945012799201612 · Cited by 329
De Petrocellis, L., Orlando, P., Moriello, A. S., Aviello, G., Stott, C., Izzo, A. A., & Di Marzo, V. (2012) · Acta Physiologica · doi:10.1111/j.1748-1716.2011.02338.x · Cited by 323
Drug treatment of epilepsy in adults
Schmidt, D., & Schachter, S. C. (2014) · BMJ · doi:10.1136/bmj.g254 · Cited by 323
Abdul, H. M., Sama, M. A., Furman, J. L., Mathis, D. M., Beckett, T. L., Weidner, A. M., Patel, E. S., Baig, I., Murphy, M. P., LeVine, H., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1064-09.2009 · Cited by 322
Jiang, R., Yamaori, S., Takeda, S., Yamamoto, I., & Watanabe, K. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.05.018 · Cited by 322
VDAC1 selectively transfers apoptotic Ca2+ signals to mitochondria
De Stefani, D., Bononi, A., Romagnoli, A., Messina, A., De Pinto, V, Pinton, P., & Rizzuto, R. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.92 · Cited by 321
García-Arencibia, M., González, S., de Lago, E., Ramos, J. A., Mechoulam, R., & Fernández-Ruiz, J. (2007) · Brain Research · doi:10.1016/j.brainres.2006.11.063 · Cited by 320
Mitochondrial Dysfunctions in Neurodegenerative Diseases: Relevance to Alzheimer’s Disease
Hroudová, J., Singh, N., & Fišar, Z. (2014) · BioMed Research International · doi:10.1155/2014/175062 · Cited by 318
Impaired Glutamate Uptake in the R6 Huntington's Disease Transgenic Mice
Liévens, J.-C., Woodman, B., Mahal, A., Spasic-Boscovic, O., Samuel, D., Kerkerian-Le Goff, L., & Bates, G. P. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0430 · Cited by 313
Elmes, M. W., Kaczocha, M., Berger, W. T., Leung, K., Ralph, B. P., Wang, L., Sweeney, J. M., Miyauchi, J. T., Tsirka, S. E., Ojima, I., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.618447 · Cited by 312
Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease
Xu, Y., Yan, J., Zhou, P., Li, J., Gao, H., Xia, Y., & Wang, Q. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.02.002 · Cited by 301
Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment
Lombardo, S., & Maskos, U. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.018 · Cited by 299
Costa, B., Giagnoni, G., Franke, C., Trovato, A. E., & Colleoni, M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705920 · Cited by 289
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
Xiong, W., Cui, T., Cheng, K., Yang, F., Chen, S.-R., Willenbring, D., Guan, Y., Pan, H.-L., Ren, K., Xu, Y., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120242 · Cited by 288
Mecha, M., Feliú, A., Iñigo, P. M., Mestre, L., Carrillo-Salinas, F. J., & Guaza, C. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.06.016 · Cited by 285
Henstridge, C. M., Balenga, N. A. B., Ford, L. A., Ross, R. A., Waldhoer, M., & Irving, A. J. (2009) · The FASEB Journal · doi:10.1096/fj.08-108670 · Cited by 285
Resstel, L. B. M., Tavares, R. F., Lisboa, S. F. S., Joca, S. R. L., Corrêa, F. M. A., & Guimarães, F. S. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00046.x · Cited by 283
Castillo, A., Tolón, M. R., Fernández-Ruiz, J., Romero, J., & Martinez-Orgado, J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.023 · Cited by 279
Ward, S. J., McAllister, S. D., Kawamura, R., Murase, R., Neelakantan, H., & Walker, E. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12439 · Cited by 276
“Is dopamine involved in Alzheimer's disease?â€
Martorana, A., & Koch, G. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00252 · Cited by 275
Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines
Massi, P., Vaccani, A., Ceruti, S., Colombo, A., Abbracchio, M. P., & Parolaro, D. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.061002 · Cited by 271
Staton, P. C., Hatcher, J. P., Walker, D. J., Morrison, A. D., Shapland, E. M., Hughes, J. P., Chong, E., Mander, P. K., Green, P. J., Billinton, A., et al. (2008) · Pain · doi:10.1016/j.pain.2008.04.006 · Cited by 270
High Density Lipoprotein Structure–Function and Role in Reverse Cholesterol Transport
Lund-Katz, S., & Phillips, M. C. (2010) · Subcellular Biochemistry · doi:10.1007/978-90-481-8622-8_7 · Cited by 262
The Religious and Medicinal Uses of Cannabis in China, India and Tibet
Touw, M. (1981) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1981.10471447 · Cited by 261
Cannabidiol Targets Mitochondria to Regulate Intracellular Ca2+Levels
Ryan, D., Drysdale, A. J., Lafourcade, C., Pertwee, R. G., & Platt, B. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4212-08.2009 · Cited by 255
Nabissi, M., Morelli, M. B., Santoni, M., & Santoni, G. (2013) · Carcinogenesis · doi:10.1093/carcin/bgs328 · Cited by 248
NFAT control of innate immunity
Fric, J., Zelante, T., Wong, A. Y. W., Mertes, A., Yu, H.-B., & Ricciardi-Castagnoli, P. (2012) · Blood · doi:10.1182/blood-2012-02-404475 · Cited by 244
Tapia, P. C. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2005.09.009 · Cited by 239
Stone, J. M., Day, F., Tsagaraki, H., Valli, I., McLean, M. A., Lythgoe, D. J., O'Gorman, R. L., Barker, G. J., & McGuire, P. K. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.05.006 · Cited by 231
Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis
Myint, A.-M., & Kim, Y.-K. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.08.008 · Cited by 230
Nrf2-regulated PPARγ Expression Is Critical to Protection against Acute Lung Injury in Mice
Cho, H.-Y., Gladwell, W., Wang, X., Chorley, B., Bell, D., Reddy, S. P., & Kleeberger, S. R. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200907-1047oc · Cited by 226
Pazos, M. R., Mohammed, N., Lafuente, H., Santos, M., Martínez-Pinilla, E., Moreno, E., Valdizan, E., Romero, J., Pazos, A., Franco, R., et al. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.027 · Cited by 225
Yamaori, S., Ebisawa, J., Okushima, Y., Yamamoto, I., & Watanabe, K. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.02.017 · Cited by 223
Hill, M. N., Kumar, S. A., Filipski, S. B., Iverson, M., Stuhr, K. L., Keith, J. M., Cravatt, B. F., Hillard, C. J., Chattarji, S., & McEwen, B. S. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.90 · Cited by 222
(2014) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199662685.001.0001 · Cited by 219
Block of Cloned Human T-Type Calcium Channels by Succinimide Antiepileptic Drugs
Gomora, J. C., Daud, A. N., Weiergräber, M., & Perez-Reyes, E. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12522-9 · Cited by 216
Sylantyev, S., Jensen, T. P., Ross, R. A., & Rusakov, D. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211204110 · Cited by 213
Successful use of fenfluramine as an add‐on treatment for Dravet syndrome
Ceulemans, B., Boel, M., Leyssens, K., Van Rossem, C., Neels, P., Jorens, P. G., & Lagae, L. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03495.x · Cited by 210 · cited 1×
“Dravet syndrome [144].”
Ren, Y., Whittard, J., Higuera-Matas, A., Morris, C. V., & Hurd, Y. L. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4291-09.2009 · Cited by 210
Xiong, H., Callaghan, D., Jones, A., Bai, J., Rasquinha, I., Smith, C., Pei, K., Walker, D., Lue, L.-F., Stanimirovic, D., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5103-08.2009 · Cited by 202
COX-2 and PPAR-γ Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells
Ramer, R., Heinemann, K., Merkord, J., Rohde, H., Salamon, A., Linnebacher, M., & Hinz, B. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0335 · Cited by 202
Moens, M.-F., & Manniche, L. (1992) · Journal of the American Oriental Society · doi:10.2307/603128 · Cited by 201
Cannabidiol Is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19
Jiang, R., Yamaori, S., Okamoto, Y., Yamamoto, I., & Watanabe, K. (2013) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-12-rg-129 · Cited by 199
Inhibition of Recombinant Human T-type Calcium Channels by Δ9-Tetrahydrocannabinol and Cannabidiol
Ross, H. R., Napier, I., & Connor, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707104200 · Cited by 199
Serpell, M., Ratcliffe, S., Hovorka, J., Schofield, M., Taylor, L., Lauder, H., & Ehler, E. (2014) · European Journal of Pain · doi:10.1002/j.1532-2149.2013.00445.x · Cited by 197 · cited 1×
“AIDS, and cancer chemotherapy [10–12].”
Phospholipases A2 and Inflammatory Responses in the Central Nervous System
Sun, G. Y., Shelat, P. B., Jensen, M. B., He, Y., Sun, A. Y., & Simonyi, A. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8092-z · Cited by 197
Cheng, D., Spiro, A. S., Jenner, A. M., Garner, B., & Karl, T. (2014) · Journal of Alzheimer’s Disease · doi:10.3233/jad-140921 · Cited by 193
Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings
Morgan, C. J. A., Das, R. K., Joye, A., Curran, H. V., & Kamboj, S. K. (2013) · Addictive Behaviors · doi:10.1016/j.addbeh.2013.03.011 · Cited by 193
Characterization of P-glycoprotein Inhibition by Major Cannabinoids from Marijuana
Zhu, H.-J., Wang, J.-S., Markowitz, J. S., Donovan, J. L., Gibson, B. B., Gefroh, H. A., & DeVane, C. L. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.098541 · Cited by 192
Luo, Z., Ma, L., Zhao, Z., He, H., Yang, D., Feng, X., Ma, S., Chen, X., Zhu, T., Cao, T., et al. (2012) · Cell Research · doi:10.1038/cr.2011.205 · Cited by 191
Elmenhorst, D., Meyer, P. T., Winz, O. H., Matusch, A., Ermert, J., Coenen, H. H., Basheer, R., Haas, H. L., Zilles, K., & Bauer, A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5066-06.2007 · Cited by 189
VDAC1: from structure to cancer therapy
Shoshan-Barmatz, V., & Mizrachi, D. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00164 · Cited by 189
Hamelink, C., Hampson, A., Wink, D. A., Eiden, L. E., & Eskay, R. L. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085779 · Cited by 189
Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice
Krohn, M., Lange, C., Hofrichter, J., Scheffler, K., Stenzel, J., Steffen, J., Schumacher, T., Brüning, T., Plath, A.-S., Alfen, F., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57867 · Cited by 183
Moussaieff, A., Rimmerman, N., Bregman, T., Straiker, A., Felder, C. C., Shoham, S., Kashman, Y., Huang, S. M., Lee, H., Shohami, E., et al. (2008) · The FASEB Journal · doi:10.1096/fj.07-101865 · Cited by 182
Anti-inflammatory lipoxin A 4 is an endogenous allosteric enhancer of CB 1 cannabinoid receptor
Pamplona, F. A., Ferreira, J., Menezes de Lima, O., Duarte, F. S., Bento, A. F., Forner, S., Villarinho, J. G., Bellocchio, L., Wotjak, C. T., Lerner, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202906109 · Cited by 179
Latta, C. H., Brothers, H. M., & Wilcock, D. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.09.061 · Cited by 178
Time-dependent vascular actions of cannabidiol in the rat aorta
O'Sullivan, S. E., Sun, Y., Bennett, A. J., Randall, M. D., & Kendall, D. A. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.03.010 · Cited by 177
Zoerner, A. A., Gutzki, F.-M., Batkai, S., May, M., Rakers, C., Engeli, S., Jordan, J., & Tsikas, D. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.08.004 · Cited by 176
Maione, S., Piscitelli, F., Gatta, L., Vita, D., De Petrocellis, L., Palazzo, E., de Novellis, V., & Di Marzo, V. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01063.x · Cited by 175
Campos, A. C., & Guimarães, F. S. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.08.017 · Cited by 172
Mazur, A., Lichti, C. F., Prather, P. L., Zielinska, A. K., Bratton, S. M., Gallus‐Zawada, A. E., Finel, M., Miller, G. P., Radominska-p, A., & Moran, J. H. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.026898 · Cited by 168
Yamaori, S., Kushihara, M., Yamamoto, I., & Watanabe, K. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.01.028 · Cited by 165 · cited 1×
“5 μM) and CYP1B1 (IC50 ~5μM) [62].”
Cannabidiol, a Major Phytocannabinoid, As a Potent Atypical Inhibitor for CYP2D6
Yamaori, S., Okamoto, Y., Yamamoto, I., & Watanabe, K. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.041384 · Cited by 164
Adenosine: setting the stage for plasticity
Dias, R. B., Rombo, D. M., Ribeiro, J. A., Henley, J. M., & Sebastião, A. M. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2012.12.003 · Cited by 163
Rimmerman, N., Ben-Hail, D., Porat, Z., Juknat, A., Kozela, E., Daniels, M. P., Connelly, P. S., Leishman, E., Bradshaw, H. B., Shoshan-Barmatz, V, et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.471 · Cited by 162
Fornal, C. A., Metzler, C. W., Gallegos, R. A., Veasey, S. C., McCreary, A. C., & Jacobs, B. L. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20660-7 · Cited by 162
WAY-100635 is a potent dopamine D4 receptor agonist
Chemel, B. R., Roth, B. L., Armbruster, B. N., Watts, V. J., & Nichols, D. E. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0490-4 · Cited by 160
Ruhaak, L. R., Felth, J., Karlsson, P. C., Rafter, J. J., Verpoorte, R., & Bohlin, L. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.774 · Cited by 160
Delta opioid receptors in brain function and diseases
Chu Sin Chung, P., & Kieffer, B. L. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.06.003 · Cited by 159
Daigle, T. L., Kearn, C. S., & Mackie, K. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.005 · Cited by 155
Cannabis-based medicine reduces multiple pathological processes in AβPP/PS1 mice
Aso, E., Sánchez-Pla, A., Vegas-Lozano, E., Maldonado, R., & Ferrer, I. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141014 · Cited by 154 · cited 1×
“Several preclinical studies have shown that CBD can exert benefit in mouse models of neurodegenerative disease [181, 182].”
BackgroundAhrens, J., Demir, R., Leuwer, M., de la Roche, J., Krampfl, K., Foadi, N., Karst, M., & Haeseler, G. (2009) · Pharmacology · doi:10.1159/000201556 · Cited by 154
Liou, G. I., Auchampach, J. A., Hillard, C. J., Zhu, G., Yousufzai, B., Mian, S., Khan, S. H., & Khalifa, Y. M. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2196 · Cited by 154
Research advances in basic mechanisms of seizures and antiepileptic drug action
Lasoń, W., Chlebicka, M., & Rejdak, K. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71060-0 · Cited by 153
The multidrug transporter ABCG2 (BCRP) is inhibited by plant‐derived cannabinoids
Holland, M. L., Lau, D. T. T., Allen, J. D., & Arnold, J. C. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707467 · Cited by 150
Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics
Miksys, S. L., Rao, Y., Hoffmann, E. B., Mash, D. C., & Tyndale, R. F. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01069.x · Cited by 150
Carrier-Mediated Uptake of the Endogenous Cannabinoid Anandamide in RBL-2H3 Cells
Rakhshan, F., Day, T. A., Blakely, R., & Barker, E. L. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35376-5 · Cited by 150
Sagredo, O., Ramos, J. A., Decio, A., Mechoulam, R., & Fernández‐Ruiz, J. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05717.x · Cited by 147
Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes.
Banerjee, S., Snyder, S. H., & Mechoulam, R. (1975) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30230-2 · Cited by 146
Ramis, M., Esteban, S., Miralles, A., Tan, D.-X., & Reiter, R. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150619104143 · Cited by 146
Massi, P., Valenti, M., Vaccani, A., Gasperi, V., Perletti, G., Marras, E., Fezza, F., Maccarrone, M., & Parolaro, D. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05073.x · Cited by 144
Magen, I., Avraham, Y., Ackerman, Z., Vorobiev, L., Mechoulam, R., & Berry, E. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00589.x · Cited by 143
Mitochondrial Ca2+ and neurodegeneration
Calí, T., Ottolini, D., & Brini, M. (2012) · Cell Calcium · doi:10.1016/j.ceca.2012.04.015 · Cited by 143
Yamaori, S., Koeda, K., Kushihara, M., Hada, Y., Yamamoto, I., & Watanabe, K. (2011) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-11-rg-107 · Cited by 142
Medvedeva, Y. V., Kim, M., & Usachev, Y. M. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4810-07.2008 · Cited by 142
Cytochrome P450 in the Brain ; A Review
Hedlund, E., Gustafsson, J.-Α., & Warner, M. N. (2001) · Current Drug Metabolism · doi:10.2174/1389200013338513 · Cited by 141
Glycine receptors and brain development
Ávila, A., Nguyen, L., & Rigo, J. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00184 · Cited by 139
Clinckers, R., Smolders, I. J., Meurs, A., Ebinger, G., & Michotte, Y. M. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02355.x · Cited by 138
Henry, B., Fox, S. H., Crossman, A. R., & Brotchie, J. M. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7727 · Cited by 138
Hunt, R. F., Hortopan, G. A., Gillespie, A. K., & Baraban, S. C. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.06.013 · Cited by 136
Tournier, N., Chevillard, L., Mégarbane, B., Pirnay, S., Scherrmann, J., & Declèves, X. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990848 · Cited by 135
Ward, S. J., Ramirez, M. D., Neelakantan, H., & Walker, E. A. (2011) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3182283486 · Cited by 133
Cannabinoid-induced changes in respiration of brain mitochondria
Fišar, Z., Singh, N., & Hroudová, J. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.09.002 · Cited by 133
Genetically deficient CYP2D6 metabolism provides protection against oral opiate dependence
Tyndale, R. F., Droll, K. P., & Sellers, E. M. (1997) · Pharmacogenetics · doi:10.1097/00008571-199710000-00006 · Cited by 132
The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosis
Keinan, N., Pahima, H. T., Ben-Hail, D., & Shoshan‐Barmatz, V. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.03.017 · Cited by 129
Hoyo-Becerra, C., Schlaak, J., & Hermann, D. M. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.200 · Cited by 129
Poddar, M. K., & Dewey, W. L. (1980) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32131-2 · Cited by 128
COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.
Müller, N. (2010) · PubMed · Cited by 122
Morelli, M. B., Offidani, M., Alesiani, F., Discepoli, G., Liberati, S., Olivieri, A., Santoni, M., Santoni, G., Leoni, P., & Nabissi, M. (2013) · International Journal of Cancer · doi:10.1002/ijc.28591 · Cited by 121
Juknat, A., Pietr, M., Kozela, E., Rimmerman, N., Levy, R., Gao, F., Coppola, G., Geschwind, D. H., & Vogel, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061462 · Cited by 121
Adamczyk, P., Miszkiel, J., McCreary, A. C., Filip, M., Papp, M., & Przegaliński, E. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.030 · Cited by 121
Marijuana in medicine: past, present and future.
Mikuriya, T. H. (1969) · PubMed · Cited by 119
The role of nicotinic acetylcholine receptors in autosomal dominant nocturnal frontal lobe epilepsy
Becchetti, A., Aracri, P., Meneghini, S., Brusco, S., & Amadeo, A. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00022 · Cited by 117
Inhibition of Anandamide Amidase Activity in Mouse Brain Microsomes by Cannabinoids.
Watanabe, K., Kayano, Y., Matsunaga, T., Yamamoto, I., & Yoshimura, H. (1996) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.19.1109 · Cited by 116
Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease
Poirier, J., Miron, J., Picard, C., Gormley, P., Théroux, L., Breitner, J. C. S., & Dea, D. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.037 · Cited by 115
Figueiredo‐Pereira, M. E., Rockwell, P., Schmidt‐Glenewinkel, T., & Serrano, P. A. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00104 · Cited by 113
Soares, V. D. P., Campos, A. C., Bortoli, V. C. D., Zangrossi, H., Guimarães, F. S., & Zuardi, A. W. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.05.004 · Cited by 112
CB1 receptor signaling regulates social anxiety and memory
Litvin, Y., Phan, A., Hill, M. N., Pfaff, D. W., & McEwen, B. S. (2013) · Genes Brain & Behavior · doi:10.1111/gbb.12045 · Cited by 111
Yang, K. S., Galadari, S., Isaev, D. S., Petroianu, G. A., Shippenberg, T. S., & Öz, M. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.162594 · Cited by 108
Ceramide inhibits the potassium channel Kv1.3 by the formation of membrane platforms
Bock, J., Szabó, I., Gamper, N. L., Adams, C., & Gulbins, E. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00763-0 · Cited by 107
TRPV1: a stress response protein in the central nervous system.
Ho, K. W., Ward, N. J., & Calkins, D. J. (2012) · Europe PMC (PubMed Central) · Cited by 106
Juknat, A., Pietr, M., Kozela, E., Rimmerman, N., Levy, R., Coppola, G., Geschwind, D. H., & Vogel, Z. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01461.x · Cited by 106
Imaging of δ‐ and μ‐opioid receptors in temporal lobe epilepsy by positron emission tomography
Madar, I., Lesser, R. P., Krauss, G. L., Zubieta, J. K., Lever, J. R., Kinter, C. M., Ravert, H. T., Musachio, J. L., Mathews, W. B., Dannals, R. F., et al. (1997) · Annals of Neurology · doi:10.1002/ana.410410311 · Cited by 106
The Effect of Cannabidiol on Ischemia/Reperfusion-Induced Ventricular Arrhythmias
Gonca, E., & Darıcı, F. (2014) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248414532013 · Cited by 106
Villikka, K., Kivistö, K. T., MAENPAA, H., JOENSUU, H., & Neuvonen, P. J. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)90067-x · Cited by 105
Reduced Hippocampal 5HT1A PET Receptor Binding and Depression in Temporal Lobe Epilepsy
Theodore, W. H., Hasler, G., Giovacchini, G., Kelley, K., Reeves‐Tyer, P., Herscovitch, P., & Drevets, W. C. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01089.x · Cited by 104
Ageing and inflammation – A central role for mitochondria in brain health and disease
Currais, A. J. M. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.02.001 · Cited by 104
Modulation of rat brain opioid receptors by cannabinoids.
VAYSSE, P. J. ‐., Gardner, E. L., & Zukin, R. S. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-5347(25)00276-9 · Cited by 103
Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1)
Holland, M. L., Allen, J. D., & Arnold, J. C. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.079 · Cited by 102
Shioda, N., Yabuki, Y., Kobayashi, Y., Onozato, M., Owada, Y., & Fukunaga, K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.527341 · Cited by 101
Hill, A. J., Jones, N. A., Smith, I., Hill, C. L., Williams, C. M., Stephens, G. J., & Whalley, B. J. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.03.013 · Cited by 100
Self-citationCosta, B., Siniscalco, D., Trovato, A. E., Comelli, F., Sotgiu, M. L., Colleoni, M., Maione, S., Rossi, F., & Giagnoni, G. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706798 · Cited by 99
CYP2D6 polymorphisms and the risk of tardive dyskinesia in schizophrenia: a meta-analysis
Patsopoulos, N. A., Ntzani, E., Zintzaras, E., & Ioannidis, J. P. A. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200503000-00003 · Cited by 99
Gonzalez‐Reyes, L. E., Ladas, T. P., Chiang, C., & Durand, D. M. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.10.010 · Cited by 96
Yang, J., Chen, J., & Fredholm, B. B. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00754.2008 · Cited by 96
Adenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia
Shen, H., Singer, P., Lytle, N. K., Wei, C. J., Lan, J., Williams-Karnesky, R. L., Chen, J., Yee, B. K., & Boison, D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62378 · Cited by 93
Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?
Reddy, P. H. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.003 · Cited by 93
GPR18 in microglia: implications for the CNS and endocannabinoid system signalling
McHugh, D. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02019.x · Cited by 92
Cannabinoids inhibit the synaptic uptake of adenosine and dopamine in the rat and mouse striatum.
Pandolfo, P., Silveirinha, V., Santos-Rodrigues, A. D., Venance, L., Ledent, C., Takahashi, R. N., Cunha, R., & Köfalvi, A. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.01.013 · Cited by 92
Sałat, K., & Filipek, B. (2015) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1400189 · Cited by 91
Adenosine A 1 , but not A 2 , Receptor Blockade Increases Anxiety and Arousal in Zebrafish
Maximino, C., Lima, M. G., Olivera, K. R. M., Picanço-Diniz, D. L. W., & Herculano, A. M. (2011) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2011.00710.x · Cited by 91
Bhaskaran, M. D., & Smith, B. N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010683 · Cited by 91
Papke, R. L., Bağdaş, D., Kulkarni, A., Gould, T., AlSharari, S. D., Thakur, G. A., & Damaj, M. I. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.002 · Cited by 87
A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice
Li, K., Fichna, J., Schicho, R., Saur, D., Bashashati, M., Mackie, K., Li, Y., Zimmer, A., Göke, B., Sharkey, K. A., et al. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.029 · Cited by 87
Pharmacological benefits of agomelatine and vanillin in experimental model of Huntington's disease
Gupta, S., & Sharma, B. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.03.022 · Cited by 86
Vilela, L., Medeiros, D. D. C., Rezende, G. H. D. S. E., de Oliveira, A. C. P., Moraes, M. F. D., & Moreira, F. A. (2013) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.11.006 · Cited by 86
Effects of cannabidiol on the function of α7-nicotinic acetylcholine receptors
Mahgoub, M., Keun-Hang, S. Y., Sydorenko, V., Ashoor, A., Kabbani, N., Kury, L. A., Sadek, B. S., Howarth, C. F., Isaev, D. S., Galadari, S., et al. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.10.011 · Cited by 85
Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK
Schmuhl, E., Ramer, R., Salamon, A., Peters, K., & Hinz, B. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.11.016 · Cited by 85
Terrando, N., Yang, T., Ryu, J. K., Newton, P. T., Monaco, C. G., Feldmann, M., Ma, D., Akassoglou, K., & Maze, M. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00143 · Cited by 84
Manna, S. S. S., & Umathe, S. N. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.02.003 · Cited by 84
Singh, N., Hroudová, J., & Fišar, Z. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0545-2 · Cited by 84
Cited by
Thiele, E. A., Marsh, E. D., French, J. A., Mazurkiewicz-Beldzinska, M., Benbadis, S. R., Joshi, C., Lyons, P. D., Taylor, A., Roberts, C., Sommerville, K., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30136-3 · Cited by 905
Antioxidative and Anti-Inflammatory Properties of Cannabidiol
Atalay, S., Jarocka-Karpowicz, I., & Skrzydlewska, E. (2019) · Antioxidants · doi:10.3390/antiox9010021 · Cited by 818
The pharmacokinetics and the pharmacodynamics of cannabinoids
Lucas, C. J., Galettis, P., & Schneider, J. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13710 · Cited by 724
Bonini, S. A., Premoli, M., Tambaro, S., Kumar, A., Maccarinelli, G., Memo, M., & Mastinu, A. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.09.004 · Cited by 669
Iffland, K., & Grotenhermen, F. (2017) · Cannabis & Cannabinoid Research · doi:10.1089/can.2016.0034 · Cited by 645
Metadata
- Authors
- Ibeas Bih, C., Chen, T., Nunn, A. V. W., Bazelot, M., Dallas, M., & Whalley, B. J.
- Venue
- Neurotherapeutics
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 12
- Issue
- 4
- Pages
- 699-730
- ISSN
- 1878-7479 (ISSN-L)
- OpenAlex
- W1166458116
- Cited by
- 578
- References
- 266
- FWCI
- 16.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.